DLCG.TO vs. ADMA

Last updated Jun 4, 2026

DLCG.TO (Dominion Lending Centres Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. DLCG.TO operates in Mortgage Finance (Financial Services), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, DLCG.TO returned 6.25%/yr vs 1.09%/yr for ADMA. At a 0.04 correlation, their price movements are largely independent.

Performance

DLCG.TO vs. ADMA - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Dominion Lending Centres Inc. (DLCG.TO) and ADMA Biologics, Inc. (ADMA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

DLCG.TO is traded in CAD, while ADMA is traded in USD. To make them comparable, the ADMA values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, DLCG.TO achieves a -13.26% return, which is significantly higher than ADMA's -56.91% return. Over the past 10 years, DLCG.TO has outperformed ADMA with an annualized return of 6.25%, while ADMA has yielded a comparatively lower 1.09% annualized return.

DLCG.TO

• 1D: 1.55%
• 1M: -9.67%
• YTD: -13.26%
• 6M: -11.30%
• 1Y: -8.17%
• 3Y*: 58.57%
• 5Y*: 20.20%
• 10Y*: 6.25%

ADMA

• 1D: 2.52%
• 1M: -23.23%
• YTD: -56.91%
• 6M: -60.80%
• 1Y: -61.58%
• 3Y*: 25.65%
• 5Y*: 38.71%
• 10Y*: 1.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DLCG.TO vs. ADMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DLCG.TO Dominion Lending Centres Inc.	-13.26%	29.71%	187.28%	-8.13%	-12.34%	22.15%	136.15%	4.00%	-45.11%	-38.57%
ADMA ADMA Biologics, Inc.	-56.91%	1.48%	312.02%	13.93%	194.79%	-28.35%	-52.07%	59.14%	-19.23%	-41.30%

Correlation

The correlation between DLCG.TO and ADMA is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.02
Correlation (10Y) Calculated over the trailing 10-year period	0.03
Correlation (All Time) Calculated using the full available price history since Oct 18, 2013	0.04

Fundamentals

Market Cap DLCG.TO : CA$663.87M ADMA : $1.86B
EPS DLCG.TO : CA$0.28 ADMA : $0.68
PE Ratio DLCG.TO : 30.16 ADMA : 11.46
PS Ratio DLCG.TO : 7.15 ADMA : 3.72
PB Ratio DLCG.TO : 4.90 ADMA : 4.77
Total Revenue (TTM) DLCG.TO : CA$97.50M ADMA : $509.86M
Gross Profit (TTM) DLCG.TO : CA$83.85M ADMA : $312.42M
EBITDA (TTM) DLCG.TO : CA$42.41M ADMA : $218.74M

Return for Risk

DLCG.TO vs. ADMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DLCG.TO

DLCG.TO Risk / Return Rank: 29
DLCG.TO Sharpe Ratio Rank: 31
DLCG.TO Sortino Ratio Rank: 27
DLCG.TO Omega Ratio Rank: 28
DLCG.TO Calmar Ratio Rank: 31
DLCG.TO Martin Ratio Rank: 29

ADMA

ADMA Risk / Return Rank: 3
ADMA Sharpe Ratio Rank: 3
ADMA Sortino Ratio Rank: 3
ADMA Omega Ratio Rank: 3
ADMA Calmar Ratio Rank: 3
ADMA Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DLCG.TO vs. ADMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dominion Lending Centres Inc. (DLCG.TO) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DLCG.TO	ADMA	Difference
Sharpe ratio Return per unit of total volatility	-0.23	-1.14	+0.91
Sortino ratio Return per unit of downside risk	-0.12	-1.82	+1.71
Omega ratio Gain probability vs. loss probability	0.99	0.76	+0.23
Calmar ratio Return relative to maximum drawdown	-0.29	-0.95	+0.66
Martin ratio Return relative to average drawdown	-0.65	-1.90	+1.25
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DLCG.TO vs. ADMA - Sharpe Ratio Comparison

The current DLCG.TO Sharpe Ratio is -0.23, which is higher than the ADMA Sharpe Ratio of -1.14. The chart below compares the historical Sharpe Ratios of DLCG.TO and ADMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DLCG.TO	ADMA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.23	-1.14	+0.91
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.41	0.66	-0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.10	0.02	+0.09
Sharpe Ratio (All Time) Calculated using the full available price history	0.06	0.03	+0.04

Drawdowns

DLCG.TO vs. ADMA - Drawdown Comparison

The maximum DLCG.TO drawdown since its inception was -98.79%, which is greater than ADMA's maximum drawdown of -90.48%. Use the drawdown chart below to compare losses from any high point for DLCG.TO and ADMA.

Drawdown Indicators

	DLCG.TO	ADMA	Difference
Max Drawdown Largest peak-to-trough decline	-98.79%	-90.48%	-8.31%
Max Drawdown (1Y) Largest decline over 1 year	-28.19%	-64.81%	+36.62%
Max Drawdown (3Y) Largest decline over 3 years	-28.19%	-68.97%	+40.78%
Max Drawdown (5Y) Largest decline over 5 years	-57.19%	-68.97%	+11.78%
Max Drawdown (10Y) Largest decline over 10 years	-87.29%	-86.72%	-0.57%
Current Drawdown Current decline from peak	-21.21%	-68.18%	+46.97%
Average Drawdown Average peak-to-trough decline	-62.06%	-48.98%	-13.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.62%	32.40%	-19.78%

Volatility

DLCG.TO vs. ADMA - Volatility Comparison

The current volatility for Dominion Lending Centres Inc. (DLCG.TO) is 11.63%, while ADMA Biologics, Inc. (ADMA) has a volatility of 20.21%. This indicates that DLCG.TO experiences smaller price fluctuations and is considered to be less risky than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DLCG.TO	ADMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.63%	20.21%	-8.58%
Volatility (6M) Calculated over the trailing 6-month period	28.54%	44.96%	-16.42%
Volatility (1Y) Calculated over the trailing 1-year period	35.71%	54.17%	-18.46%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	49.29%	59.18%	-9.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.69%	68.89%	-8.20%

Dividends

DLCG.TO vs. ADMA - Dividend Comparison

DLCG.TO's dividend yield for the trailing twelve months is around 1.99%, while ADMA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ADMA ADMA Biologics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DLCG.TO Dominion Lending Centres Inc.	1.99%	1.51%	1.54%	4.29%	2.81%	0.00%	0.00%	0.00%	4.16%	2.21%	0.00%	116.00%

Financials

DLCG.TO vs. ADMA - Profitability Comparison

The chart below illustrates the profitability comparison between Dominion Lending Centres Inc. and ADMA Biologics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DLCG.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dominion Lending Centres Inc. reported a gross profit of 16.32M and revenue of 19.95M. Therefore, the gross margin over that period was 81.8%.

ADMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.

DLCG.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dominion Lending Centres Inc. reported an operating income of 7.15M and revenue of 19.95M, resulting in an operating margin of 35.8%.

ADMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.

DLCG.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dominion Lending Centres Inc. reported a net income of 4.80M and revenue of 19.95M, resulting in a net margin of 24.1%.

ADMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.

Frequently Asked Questions

Can I hold both DLCG.TO and ADMA in my portfolio?

DLCG.TO and ADMA have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.